Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹7,268Cr
Packaging - FMCG/Consumers
Rev Gr TTM
Revenue Growth TTM
10.42%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

EPL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 10.1 | 9.4 | 5.6 | 3.2 | 6.2 | 10.7 | 8.4 | 4.0 | 7.4 | 10.0 | 11.0 | 13.3 |
| 815 | 751 | 821 | 792 | 838 | 822 | 866 | 813 | 877 | 881 | 954 | 918 |
Operating Profit Operating ProfitCr |
| 15.9 | 17.5 | 18.1 | 18.8 | 18.6 | 18.4 | 20.3 | 19.9 | 20.6 | 20.5 | 20.9 | 20.1 |
Other Income Other IncomeCr | 27 | 11 | 11 | 25 | -44 | 6 | 12 | 13 | 11 | 8 | 12 | 2 |
Interest Expense Interest ExpenseCr | 21 | 24 | 31 | 29 | 32 | 29 | 29 | 27 | 28 | 28 | 29 | 29 |
Depreciation DepreciationCr | 79 | 80 | 84 | 84 | 85 | 84 | 85 | 86 | 88 | 90 | 94 | 97 |
| 82 | 66 | 78 | 94 | 30 | 80 | 118 | 101 | 123 | 117 | 141 | 107 |
| -3 | 11 | 25 | 7 | 15 | 14 | 30 | 6 | 7 | 16 | 35 | 24 |
|
Growth YoY PAT Growth YoY% | 69.9 | 58.9 | 9.4 | 38.6 | -82.3 | 18.2 | 69.5 | 7.8 | 666.2 | 54.3 | 20.2 | -11.7 |
| 8.8 | 6.1 | 5.2 | 8.9 | 1.5 | 6.5 | 8.1 | 9.3 | 10.5 | 9.2 | 8.8 | 7.2 |
| 2.6 | 1.7 | 1.6 | 2.7 | 0.7 | 2.0 | 2.7 | 2.9 | 3.6 | 3.1 | 3.3 | 2.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 9.2 | -8.4 | 8.2 | 5.3 | 11.7 | 2.0 | 12.0 | 11.0 | 7.6 | 6.0 | 7.6 | 8.4 |
| 1,932 | 1,724 | 1,880 | 1,959 | 2,208 | 2,204 | 2,481 | 2,857 | 3,116 | 3,202 | 3,377 | 3,631 |
Operating Profit Operating ProfitCr |
| 16.8 | 19.0 | 18.3 | 19.2 | 18.4 | 20.2 | 19.8 | 16.8 | 15.6 | 18.2 | 19.8 | 20.5 |
Other Income Other IncomeCr | 26 | 31 | 52 | 20 | 37 | 3 | -3 | 4 | 38 | 2 | 42 | 33 |
Interest Expense Interest ExpenseCr | 79 | 61 | 58 | 55 | 61 | 56 | 43 | 40 | 67 | 116 | 114 | 114 |
Depreciation DepreciationCr | 132 | 123 | 141 | 167 | 186 | 230 | 235 | 251 | 281 | 333 | 343 | 368 |
| 206 | 251 | 274 | 263 | 289 | 275 | 331 | 289 | 268 | 268 | 422 | 488 |
| 61 | 78 | 79 | 89 | 93 | 64 | 87 | 68 | 37 | 58 | 58 | 82 |
|
| 29.9 | 19.4 | 13.0 | -10.9 | 12.2 | 8.3 | 15.4 | -9.4 | 4.3 | -8.9 | 73.2 | 11.7 |
| 6.2 | 8.1 | 8.5 | 7.2 | 7.2 | 7.7 | 7.9 | 6.5 | 6.3 | 5.4 | 8.6 | 8.9 |
| 4.5 | 5.4 | 6.1 | 2.7 | 6.1 | 6.6 | 7.6 | 6.8 | 7.2 | 6.7 | 11.3 | 12.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 31 | 31 | 31 | 31 | 63 | 63 | 63 | 63 | 64 | 64 | 64 | 64 |
| 729 | 933 | 1,008 | 1,219 | 1,325 | 1,470 | 1,635 | 1,761 | 1,926 | 2,028 | 2,291 | 2,560 |
Current Liabilities Current LiabilitiesCr | 626 | 443 | 545 | 666 | 574 | 792 | 773 | 896 | 963 | 1,084 | 1,152 | 1,329 |
Non Current Liabilities Non Current LiabilitiesCr | 665 | 603 | 669 | 522 | 553 | 472 | 507 | 537 | 677 | 634 | 495 | 500 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1,004 | 922 | 964 | 1,134 | 1,093 | 1,340 | 1,344 | 1,532 | 1,623 | 1,647 | 1,734 | 2,004 |
Non Current Assets Non Current AssetsCr | 1,055 | 1,097 | 1,295 | 1,308 | 1,427 | 1,466 | 1,667 | 1,759 | 2,010 | 2,162 | 2,271 | 2,455 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 313 | 361 | 369 | 343 | 356 | 471 | 522 | 312 | 602 | 587 | 795 |
Investing Cash Flow Investing Cash FlowCr | -145 | -46 | -301 | -156 | -188 | -119 | -281 | -264 | -389 | -344 | -376 |
Financing Cash Flow Financing Cash FlowCr | -168 | -320 | -76 | -154 | -194 | -142 | -319 | -95 | -138 | -263 | -431 |
|
Free Cash Flow Free Cash FlowCr | 114 | 165 | 162 | 206 | 56 | 364 | 526 | 320 | 606 | 589 | 802 |
| 215.8 | 208.4 | 188.5 | 197.2 | 182.4 | 222.6 | 213.8 | 140.8 | 260.9 | 279.1 | 218.6 |
CFO To EBITDA CFO To EBITDA% | 80.1 | 89.4 | 87.4 | 73.9 | 71.4 | 84.5 | 85.5 | 54.1 | 104.2 | 82.1 | 95.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 1,959 | 2,530 | 3,725 | 3,781 | 3,680 | 4,877 | 7,436 | 6,114 | 5,152 | 5,670 | 6,460 |
Price To Earnings Price To Earnings | 15.2 | 14.9 | 19.6 | 22.0 | 19.1 | 23.5 | 31.1 | 28.6 | 22.7 | 26.6 | 18.0 |
Price To Sales Price To Sales | 0.8 | 1.2 | 1.6 | 1.6 | 1.4 | 1.8 | 2.4 | 1.8 | 1.4 | 1.4 | 1.5 |
Price To Book Price To Book | 2.5 | 2.6 | 3.6 | 3.0 | 2.6 | 3.2 | 4.4 | 3.4 | 2.6 | 2.7 | 2.7 |
| 6.7 | 7.6 | 10.2 | 9.0 | 8.3 | 9.2 | 12.8 | 11.6 | 10.0 | 8.9 | 8.4 |
Profitability Ratios Profitability Ratios |
| 51.1 | 56.6 | 56.2 | 57.2 | 57.0 | 58.1 | 58.2 | 55.8 | 54.7 | 57.7 | 58.8 |
| 16.8 | 19.0 | 18.3 | 19.2 | 18.4 | 20.2 | 19.8 | 16.8 | 15.6 | 18.2 | 19.8 |
| 6.2 | 8.1 | 8.5 | 7.2 | 7.2 | 7.7 | 7.9 | 6.5 | 6.3 | 5.4 | 8.6 |
| 18.7 | 19.7 | 19.2 | 17.2 | 17.8 | 15.4 | 16.0 | 12.7 | 11.7 | 12.8 | 17.0 |
| 19.1 | 17.9 | 18.8 | 13.9 | 14.1 | 13.8 | 14.4 | 12.1 | 11.6 | 10.1 | 15.4 |
| 7.0 | 8.6 | 8.7 | 7.1 | 7.8 | 7.5 | 8.1 | 6.7 | 6.3 | 5.5 | 9.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
EPL Ltd (formerly Essel Propack Limited) is the **world’s largest manufacturer of laminated plastic tubes**, serving the **FMCG and pharmaceutical industries** across **10–11 countries** through **20–21 advanced manufacturing facilities**. The company produces over **8 billion tubes annually** and is a global leader in specialty packaging solutions, with a strong footprint in **Oral Care, Beauty & Cosmetics, Pharma & Health, Food, and Home Care** segments.
With more than **5,700 employees from over 24 nationalities**, EPL operates globally across **AMESA (Africa, Middle East, South Asia), EAP (East Asia-Pacific), Europe, and the Americas**. It has evolved from an oral care-focused business to a diversified packaging leader, with **over 50% of revenue now derived from non-oral categories**, especially **Beauty & Cosmetics (B&C)**.
---
### **Strategic Growth & Market Position**
#### **1. Leading Market Share & Diversified Portfolio**
- Holds #1 position in **global oral care packaging**, supplying **one in every three toothpaste tubes** worldwide.
- Leading global market share (~36%) in oral care, with growing wallet share among top FMCG clients including **Colgate, P&G, Unilever, GSK, Johnson & Johnson, and Haleon**.
- The **‘Personal Care & Beyond’** segment (Beauty & Cosmetics, Pharma, Food, Home) now accounts for **over 50% of total revenue**, growing at a **~13% CAGR over the past 14 years**.
- Beauty & Cosmetics has emerged as the primary growth engine, with **double-digit revenue growth for two consecutive quarters in 2025**.
#### **2. Geographic Expansion**
- Manufacturing footprint spans the **USA, Mexico, Colombia, Brazil, Poland, Germany, Egypt, China, Philippines, Indonesia, and India**.
- Strategic **greenfield projects** launched:
- **Thailand plant inaugurated in Nov 2025**, built in **9 months**, targeting Southeast Asia exports.
- **Brazil plant stabilized and growing rapidly**, already margin-accretive, serving anchor and new multinational customers. EPL is the **only strategic global tube supplier in Brazil**, giving it a first-mover advantage.
- **Local-for-local manufacturing** model minimizes trade risks—tubes sold in the **U.S. are made in the U.S.**, avoiding import tariffs.
#### **3. Targeted Growth in High-Potential Markets**
- **Europe**: Low market share (~4% in B&C) indicates significant upside; strategic leadership changes and M&A evaluation underway to accelerate penetration.
- **China & East Asia Pacific**: Export hub, growing at **20% YoY over five years**, with strong momentum despite macro volatility.
- **India**: Strategic base for innovation and cost leadership, with expanding presence in pharma, beauty, and hygiene.
---
### **Innovation & Technology Leadership**
#### **1. Proprietary Product Innovations**
- **Platina Series**: World’s **first 100% recyclable laminated tube** (including cap and shoulder), certified by **APR (USA)** and **RecyClass Europe (Code 2 HDPE)**.
- Accounts for **38% of total production volume** in 2025.
- Key clients: **Colgate, Haleon, Sunsilk, Unilever, P&G**.
- **Neo Seam™ Technology**:
- Eliminates side seam visibility for 360° printing, matching extruded tube aesthetics.
- **EBITDA margin accretive**, commercialized globally, driving B&C growth.
- Supports entry into niche formats (e.g., spring masks, glucose tubes, anti-itch ointments).
- **eMetal Printing**: First-in-industry **metal deposit printing without PE liner**, enhancing sustainability and visual impact.
- **New Formats**: Tube-in-tube, precise dosage control tubes, airless pump tubes, sculpting roller tubes, and dry hair gel packaging.
#### **2. Advanced Manufacturing Capabilities**
- End-to-end **integrated manufacturing**: Film extrusion, lamination, printing (flexo, digital, foil), tube forming, cap molding.
- **Digital printing capacity expanded globally**, with **HP Indigo 8K presses**, enabling **personalization, small MOQs, and rapid turnaround**.
- State-of-the-art **16-station extrusion machines** and **9-layer blown film lines** enhance quality and capacity.
- SAP **S/4HANA** runs across all global facilities; digitization via **ePAD (shopfloor automation), eACT (digital artwork collaboration)**, and AI/ML for process optimization.
#### **3. Sustainability Leadership**
- Achieved **EcoVadis Platinum rating (Nov 2025)**—top 1% of 150,000 assessed companies globally.
- **38% of total production is recyclable**, with 50% of offerings designed for **HDPE recyclability**.
- Key initiatives:
- **Project Liberty**: Full recyclability of **aluminum-based laminated (ABL) tubes** via polymer-aluminum separation.
- **Green Maple Leaf & Etain tubes**: Made with **post-consumer recycled (PCR) resin**, targeting food and cosmetics.
- Carbon footprint reduction through **thin-wall designs, waste minimization (War on Waste)**, and renewable energy (e.g., 49% stake in Clean Max Aria for wind/solar power).
---
### **Commercial & Sales Strategy**
#### **1. Dual Sales Model**
- **Key Account Management**: For large oral care clients.
- **Frontline Sales Expansion**: Dedicated "hunting" teams added (+20% headcount) to target **smaller, fragmented B&C customers**, especially in Europe and the Americas.
- Focus on **agility, innovation, and shorter lead times** for small-volume, high-mix orders.
#### **2. Market Transformation**
- Driving format shifts:
- **Bottles → tubes**: Honey, hair gel.
- **Aluminum → co-extruded acrylic & laminated tubes**: Sustainability and performance upgrade.
- **Rigid packaging → tubes**: Food, home care, pet care (e.g., cat/dog lice treatment).
#### **3. M&A & Partnerships**
- **Strategic M&A agenda** in **Beauty & Cosmetics** and **extruded tubes**, focusing on **Europe** for market entry.
- **Indorama Ventures (IVL)** invested in EPL (Mar 2025), validating its model and enabling **expansion into Southeast Asia and Africa** via IVL’s regional strength.
- Acquired **CSPL (Creative Stylo Packs)**, enhancing plastic extrusion and cap molding capabilities.
- Joint ventures in **Indonesia** and **Germany (EDG)** extend geographic reach.
---
### **Recent Developments (2025)**
- Inaugurated **Thailand plant**—strategic SE Asia gateway.
- Expanded **60mm diameter tube manufacturing**.
- Won business in **Brazil, Thailand, Australia, Taiwan, Myanmar**.
- Commercialized **Precise Dosage Control Tubes, Tube-in-Tube, spring masks**.
- Strengthened **digital showroom, AI tools, and ePAD rollout** in USA, Mexico, Colombia.
---